Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 2 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
SanaClis from Diepenbeek, company number BE1010302411, closed financial year 2025 with a result of € -31,824 after tax. For that financial year SanaClis recorded a gross margin of € 104,880 and equity of € -29,357. Compared with financial year 2024, the result moved from € -47,533 to € -31,824. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 19, 2026.
€ -29,357
▼ € 31,824 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -31,824
▲ 33 % less loss than in 2024
Profit after tax over the fiscal year.
€ 20,690
▲ 64% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -79,357.
People and assets in 2025
1
Average over the fiscal year, from the social balance sheet.
€ 131,878
▲ 56% vs 2024
€ 131,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 40,000
▲ 300% vs 2024
Loans from banks and other lenders, long and short.
€ 16,030
▲ 44% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 18,110
▲ 4% vs 2024
Taxes, VAT and social contributions still to pay.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 38,408 | € 104,880 | ▲ 173% |
| Profit after taxes | € -47,533 | € -31,824 | ▲ € 15,710 |
| Equity | € 2,467 | € -29,357 | ▼ € 31,824 |
| Total debts | € 38,525 | € 75,900 | ▲ 97% |
| Cash | € 12,643 | € 20,690 | ▲ 64% |
| Retained profit | € -47,533 | € -79,357 | ▼ € 31,824 |
| Bank debt | € 10,000 | € 40,000 | ▲ 300% |
| Balance sheet total | € 40,992 | € 46,543 | ▲ 14% |
| Employees (FTE) | 1 | 1 |
By gross margin, SanaClis ranks 5th of 12 companies with main activity “Speur- en ontwikkelingswerk op biotechnologisch gebied” in Diepenbeek that publish figures (fiscal year 2025).
Key figures of SanaClis, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about SanaClis the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to SanaClis?
What happened at SanaClis in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 31,824. Source: NBB ↗
- New establishment in Diepenbeek. KBO
- ROMAN HRYNCHUK became a director. NBB
- ALEXANDER FETKOVSKY became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 47,533 loss in 2024 to € 31,824 loss in 2025.
Paid € 223 in corporate taxes since 2024.
On average € 104,900 of value added per employee in 2025.
Management
Behind SanaClis are ROMAN HRYNCHUK and ALEXANDER FETKOVSKY.
Directors
According to the 2025 annual accounts
ROMAN HRYNCHUK
Director
since 2024
ALEXANDER FETKOVSKY
Director
since 2024
Establishments
Establishment units
Physical locations of this company
Wetenschapspark 11
3590 Diepenbeek
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Diepenbeek
Same main activity (Speur- en ontwikkelingswerk op biotechnologisch gebied), 11 active companies in Diepenbeek, largest first.
€ 3.1 million gross margin · 2025
€ 3.1 million gross margin · 2025
€ 1.6 million gross margin · 2025
€ 195,494 gross margin · 2025
€ 15,228 gross margin · 2025
€ -7,311 gross margin · 2025
Details
- Company number
- 1010.302.411
- VAT number
- BE 1010.302.411
- Registered office
- Wetenschapspark 11, 3590 Diepenbeek
- Names & denominations
- SanaClis
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 12 June 2024
- Peppol
- Active · Active since 12 Sept 2024
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied